Similar articles for PMID: 19119263

Year	Number of Results
1990	1
1992	1
1994	1
1995	1
1996	5
1997	2
2001	4
2002	3
2003	7
2004	6
2005	3
2006	15
2007	5
2008	8
2009	4
2010	9
2011	6
2012	8
2013	5
2014	5
2015	6
2016	4
2017	4
2018	1
2019	3
2020	1
2021	2
2022	1
2023	2
2024	0

1

G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions.

Bhatnagar V, O'Connor DT, Brophy VH, Schork NJ, Richard E, Salem RM, Nievergelt CM, Bakris GL, Middleton JP, Norris KC, Wright J, Hiremath L, Contreras G, Appel LJ, Lipkowitz MS; AASK Study Investigators. Bhatnagar V, et al. Am J Hypertens. 2009 Mar;22(3):332-8. doi: 10.1038/ajh.2008.341. Epub 2009 Jan 1. Am J Hypertens. 2009. PMID: 19119263 Free PMC article.

2

G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.

Vandell AG, Lobmeyer MT, Gawronski BE, Langaee TY, Gong Y, Gums JG, Beitelshees AL, Turner ST, Chapman AB, Cooper-DeHoff RM, Bailey KR, Boerwinkle E, Pepine CJ, Liggett SB, Johnson JA. Vandell AG, et al. Hypertension. 2012 Oct;60(4):957-64. doi: 10.1161/HYPERTENSIONAHA.112.198721. Epub 2012 Sep 4. Hypertension. 2012. PMID: 22949529 Free PMC article.

3

The importance of G protein-coupled receptor kinase 4 (GRK4) in pathogenesis of salt sensitivity, salt sensitive hypertension and response to antihypertensive treatment.

Rayner B, Ramesar R. Rayner B, et al. Int J Mol Sci. 2015 Mar 12;16(3):5741-9. doi: 10.3390/ijms16035741. Int J Mol Sci. 2015. PMID: 25775155 Free PMC article. Review.

4

Genetic variants of GRK4 influence circadian rhythm of blood pressure and response to candesartan in hypertensive patients.

Cao N, Tang H, Tian M, Gong X, Xu Z, Zhou B, Lan C, Chen C, Qu S, Zheng S, Ren H, Fan C, Jose PA, Zeng C, Xia T. Cao N, et al. Clin Exp Hypertens. 2021 Oct 3;43(7):597-603. doi: 10.1080/10641963.2021.1919357. Epub 2021 Apr 25. Clin Exp Hypertens. 2021. PMID: 33899625 Free PMC article.

5

The G protein-coupled receptor kinase 4 gene affects blood pressure in young normotensive twins.

Zhu H, Lu Y, Wang X, Treiber FA, Harshfield GA, Snieder H, Dong Y. Zhu H, et al. Am J Hypertens. 2006 Jan;19(1):61-6. doi: 10.1016/j.amjhyper.2005.07.007. Am J Hypertens. 2006. PMID: 16461192

6

Serum potassium predicts time to blood pressure response among African Americans with hypertensive nephrosclerosis.

Bhalla M, Aziz H, Richard E, Lipkowitz MS, Bhatnagar V. Bhalla M, et al. J Hum Hypertens. 2013 Jun;27(6):393-6. doi: 10.1038/jhh.2012.47. Epub 2012 Nov 15. J Hum Hypertens. 2013. PMID: 23151750 Free PMC article. Clinical Trial.

7

β(1)-adrenergic receptor polymorphisms and response to β-blockade in the African-American study of kidney disease and hypertension (AASK).

Lee J, Aziz H, Liu L, Lipkowitz M, O'Connor DT, Richard E, Brophy V, Wassel CL, Blantz R; AASK Study Investigators; Bhatnagar V. Lee J, et al. Am J Hypertens. 2011 Jun;24(6):694-700. doi: 10.1038/ajh.2011.39. Epub 2011 Mar 17. Am J Hypertens. 2011. PMID: 21415838 Clinical Trial.

8

G-protein receptor kinase 4 polymorphism and response to antihypertensive therapy.

Muskalla AM, Suter PM, Saur M, Nowak A, Hersberger M, Krayenbuehl PA. Muskalla AM, et al. Clin Chem. 2014 Dec;60(12):1543-8. doi: 10.1373/clinchem.2014.226605. Epub 2014 Oct 9. Clin Chem. 2014. PMID: 25301854

9

Progression of chronic kidney disease: Adrenergic genetic influence on glomerular filtration rate decline in hypertensive nephrosclerosis.

Chen Y, Lipkowitz MS, Salem RM, Fung MM, Bhatnagar V, Mahata M, Nievergelt CM, Rao F, Mahata SK, Schork NJ, Hicks PJ, Bowden DW, Freedman BI, Brophy VH, O'Connor DT; AASK. Chen Y, et al. Am J Nephrol. 2010;32(1):23-30. doi: 10.1159/000313927. Epub 2010 May 19. Am J Nephrol. 2010. PMID: 20484896 Free PMC article.

10

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG; African American Study of Kidney Disease and Hypertension Study Group. Wright JT Jr, et al. JAMA. 2002 Nov 20;288(19):2421-31. doi: 10.1001/jama.288.19.2421. JAMA. 2002. PMID: 12435255 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

113 results

Results by year